MCRO fundamentals
An in-depth look to MACRO GROUP PHARMACEUTICALS -MACRO CAPITAL operating, investing, and financing activities
MCRO free cash flow for Q3 23 is -78.12 M EGP. For 2023, MCRO free cash flow was -42.46 M EGP and operating cash flow was -36.03 M EGP.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM